Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help
Search by PDB author
5RXN
DownloadVisualize
BU of 5rxn by Molmil
COMBINED CRYSTALLOGRAPHIC REFINEMENT AND ENERGY MINIMIZATION OF RUBREDOXIN AT 1.2 ANGSTROM RESOLUTION
Descriptor: FE (III) ION, RUBREDOXIN
Authors:Watenpaugh, K.D.
Deposit date:1984-10-15
Release date:1985-04-01
Last modified:2024-03-06
Method:X-RAY DIFFRACTION (1.2 Å)
Cite:Combined Crystallographic Refinement and Energy Minimization of Rubredoxin at 1.2 Angstrom Resolution
To be Published
4RXN
DownloadVisualize
BU of 4rxn by Molmil
CRYSTALLOGRAPHIC REFINEMENT OF RUBREDOXIN AT 1.2 ANGSTROMS RESOLUTION
Descriptor: FE (III) ION, RUBREDOXIN
Authors:Watenpaugh, K.D, Sieker, L.C, Jensen, L.H.
Deposit date:1984-10-15
Release date:1985-04-01
Last modified:2024-02-28
Method:X-RAY DIFFRACTION (1.2 Å)
Cite:Crystallographic refinement of rubredoxin at 1 x 2 A degrees resolution.
J.Mol.Biol., 138, 1980
1FX1
DownloadVisualize
BU of 1fx1 by Molmil
A CRYSTALLOGRAPHIC STRUCTURAL STUDY OF THE OXIDATION STATES OF DESULFOVIBRIO VULGARIS FLAVODOXIN
Descriptor: FLAVIN MONONUCLEOTIDE, FLAVODOXIN
Authors:Watenpaugh, K.D, Sieker, L.C, Jensen, L.H.
Deposit date:1984-10-15
Release date:1985-01-02
Last modified:2024-05-22
Method:X-RAY DIFFRACTION (2 Å)
Cite:A Crystallographic Structural Study of the Oxidation States of Desulfovibrio Vulgaris Flavodoxin
Flavins and Flavoproteins, 1976
6UPJ
DownloadVisualize
BU of 6upj by Molmil
HIV-2 PROTEASE/U99294 COMPLEX
Descriptor: 6,7,8,9-TETRAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOHEPTA[B]PYRAN-2-ONE, HIV-2 PROTEASE
Authors:Watenpaugh, K.D, Mulichak, A.M, Finzel, B.C.
Deposit date:1996-12-10
Release date:1997-04-21
Last modified:2024-04-03
Method:X-RAY DIFFRACTION (2.34 Å)
Cite:Use of medium-sized cycloalkyl rings to enhance secondary binding: discovery of a new class of human immunodeficiency virus (HIV) protease inhibitors.
J.Med.Chem., 38, 1995
5UPJ
DownloadVisualize
BU of 5upj by Molmil
HIV-2 PROTEASE/U99283 COMPLEX
Descriptor: 5,6,7,8,9,10-HEXAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOOCTA[B]PYRAN-2-ONE, HIV-2 PROTEASE
Authors:Watenpaugh, K.D, Mulichak, A.M, Finzel, B.C.
Deposit date:1996-12-10
Release date:1997-04-21
Last modified:2024-04-03
Method:X-RAY DIFFRACTION (2.3 Å)
Cite:Use of medium-sized cycloalkyl rings to enhance secondary binding: discovery of a new class of human immunodeficiency virus (HIV) protease inhibitors.
J.Med.Chem., 38, 1995
7UPJ
DownloadVisualize
BU of 7upj by Molmil
HIV-1 PROTEASE/U101935 COMPLEX
Descriptor: HIV-1 PROTEASE, N-(3-CYCLOPROPYL(5,6,7,8,9,10-HEXAHYDRO-2-OXO-2H-CYCLOOCTA[B]PYRAN-3-YL)METHYL)PHENYLBENZENSULFONAMIDE
Authors:Watenpaugh, K.D, Janakiraman, M.N.
Deposit date:1996-12-05
Release date:1997-04-21
Last modified:2024-04-03
Method:X-RAY DIFFRACTION (2 Å)
Cite:Structure-based design of nonpeptidic HIV protease inhibitors: the sulfonamide-substituted cyclooctylpyramones.
J.Med.Chem., 40, 1997
1HPO
DownloadVisualize
BU of 1hpo by Molmil
HIV-1 PROTEASE TRIPLE MUTANT/U103265 COMPLEX
Descriptor: 4-CYANO-N-(3-CYCLOPROPYL(5,6,7,8,9,10-HEXAHYDRO-4-HYDROXY-2-OXO-CYCLOOCTA[B]PYRAN-3-YL)METHYL)PHENYL BENZENSULFONAMIDE, HIV-1 PROTEASE
Authors:Watenpaugh, K.D, Janakiraman, M.N.
Deposit date:1996-12-10
Release date:1997-04-21
Last modified:2024-02-07
Method:X-RAY DIFFRACTION (2.5 Å)
Cite:Structure-based design of nonpeptidic HIV protease inhibitors: the sulfonamide-substituted cyclooctylpyramones.
J.Med.Chem., 40, 1997
3UPJ
DownloadVisualize
BU of 3upj by Molmil
HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 PROTEASE MUTANT WITH LYS 57 REPLACED BY LEU (K57L) COMPLEX WITH U096333 [4-HYDROXY-3-[1-(PHENYL)PROPYL]-7-METHOXYCOUMARIN]
Descriptor: 4-HYDROXY-7-METHOXY-3-(1-PHENYL-PROPYL)-CHROMEN-2-ONE, HIV-2 PROTEASE
Authors:Watenpaugh, K.D, Mulichak, A.M, Janakiraman, M.N.
Deposit date:1996-03-04
Release date:1996-10-14
Last modified:2024-04-03
Method:X-RAY DIFFRACTION (2.5 Å)
Cite:Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitors.
J.Med.Chem., 38, 1995
2UPJ
DownloadVisualize
BU of 2upj by Molmil
HIV-1 PROTEASE COMPLEX WITH U100313 ([3-[[3-[CYCLOPROPYL [4-HYDROXY-2OXO-6-[1-(PHENYLMETHYL)PROPYL]-2H-PYRAN-3-YL] METHYL]PHENYL]AMINO]-3-OXO-PROPYL]CARBAMIC ACID TERT-BUTYL ESTER)
Descriptor: HIV-1 PROTEASE, [2-(3-{[6-(1-BENZYL-PROPYL)-4-HYDROXY-2-OXO-2H-PYRAN-3-YL]-CYCLOPROPYL-METHYL}-PHENYLCARBAMOYL)-ETHYL]-CARBAMIC ACID TERT-BUTYL ESTER
Authors:Watenpaugh, K.D, Mulichak, A.M, Janakiraman, M.N.
Deposit date:1996-03-04
Release date:1996-10-14
Last modified:2024-04-03
Method:X-RAY DIFFRACTION (3 Å)
Cite:Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitors.
J.Med.Chem., 38, 1995
1UPJ
DownloadVisualize
BU of 1upj by Molmil
HIV-1 PROTEASE COMPLEX WITH U095438 [3-[1-(4-BROMOPHENYL) ISOBUTYL]-4-HYDROXYCOUMARIN
Descriptor: 3-[1-(4-BROMO-PHENYL)-2-METHYL-PROPYL]-4-HYDROXY-CHROMEN-2-ONE, HIV-1 PROTEASE
Authors:Watenpaugh, K.D, Mulichak, A.M, Janakiraman, M.N.
Deposit date:1996-03-04
Release date:1996-10-14
Last modified:2024-04-03
Method:X-RAY DIFFRACTION (2.22 Å)
Cite:Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitors.
J.Med.Chem., 38, 1995
4UPJ
DownloadVisualize
BU of 4upj by Molmil
HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 PROTEASE MUTANT WITH LYS 57 REPLACED BY LEU (K57L) COMPLEX WITH U097410 [4-HYDROXY-3-[1-[3-[[[[(TERT-BUTYLOXYCARBONYL) AMINOMETHYL]CARBONYL]AMINO]PHENYL]PROPYL]COUMARIN
Descriptor: ({3-[1-(4-HYDROXY-2-OXO-2H-CHROMEN-3-YL)-PROPYL]-PHENYLCARBAMOYL}-METHYL)-CARBAMIC ACID TERT-BUTYL ESTER, HIV-2 PROTEASE
Authors:Watenpaugh, K.D, Mulichak, A.M, Janakiraman, M.N.
Deposit date:1996-03-04
Release date:1996-10-14
Last modified:2024-04-03
Method:X-RAY DIFFRACTION (1.9 Å)
Cite:Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitors.
J.Med.Chem., 38, 1995
1QB0
DownloadVisualize
BU of 1qb0 by Molmil
HUMAN CDC25B CATALYTIC DOMAIN
Descriptor: BETA-MERCAPTOETHANOL, CHLORIDE ION, PROTEIN (M-PHASE INDUCER PHOSPHATASE 2 (CDC25B)), ...
Authors:Watenpaugh, K.D, Reynolds, R.A.
Deposit date:1999-04-29
Release date:2000-04-29
Last modified:2018-02-28
Method:X-RAY DIFFRACTION (1.91 Å)
Cite:Crystal structure of the catalytic subunit of Cdc25B required for G2/M phase transition of the cell cycle.
J.Mol.Biol., 293, 1999
1JSV
DownloadVisualize
BU of 1jsv by Molmil
The structure of cyclin-dependent kinase 2 (CDK2) in complex with 4-[(6-amino-4-pyrimidinyl)amino]benzenesulfonamide
Descriptor: 4-[(6-AMINO-4-PYRIMIDINYL)AMINO]BENZENESULFONAMIDE, CELL DIVISION PROTEIN KINASE 2
Authors:Watenpaugh, K.D, Kelley, L.C.
Deposit date:2001-08-19
Release date:2001-08-29
Last modified:2024-02-07
Method:X-RAY DIFFRACTION (1.96 Å)
Cite:The cyclin-dependent kinases cdk2 and cdk5 act by a random, anticooperative kinetic mechanism
J.Biol.Chem., 276, 2001
1CWS
DownloadVisualize
BU of 1cws by Molmil
HUMAN CDC25B CATALYTIC DOMAIN WITH TUNGSTATE
Descriptor: BETA-MERCAPTOETHANOL, CDC25 B-TYPE TYROSINE PHOSPHATASE, CHLORIDE ION, ...
Authors:Watenpaugh, K.D, Reynolds, R.A, Chidester, C.G.
Deposit date:1999-08-26
Release date:2000-08-30
Last modified:2011-07-13
Method:X-RAY DIFFRACTION (2 Å)
Cite:Crystal structure of the catalytic subunit of Cdc25B required for G2/M phase transition of the cell cycle.
J.Mol.Biol., 293, 1999
1CWR
DownloadVisualize
BU of 1cwr by Molmil
HUMAN CDC25B CATALYTIC DOMAIN WITHOUT ION IN CATALYTIC SITE
Descriptor: BETA-MERCAPTOETHANOL, PROTEIN (M-PHASE INDUCER PHOSPHATASE 2 (CDC25B)), SULFATE ION
Authors:Watenpaugh, K.D, Reynolds, R.A, Chidester, C.G.
Deposit date:1999-08-26
Release date:2000-08-28
Last modified:2023-12-06
Method:X-RAY DIFFRACTION (2.1 Å)
Cite:Crystal structure of the catalytic subunit of Cdc25B required for G2/M phase transition of the cell cycle.
J.Mol.Biol., 293, 1999
1CWT
DownloadVisualize
BU of 1cwt by Molmil
HUMAN CDC25B CATALYTIC DOMAIN WITH METHYL MERCURY
Descriptor: CDC25 B-TYPE TYROSINE PHOSPHATASE, CHLORIDE ION, METHYL MERCURY ION, ...
Authors:Watenpaugh, K.D, Reynolds, R.A.
Deposit date:1999-08-26
Release date:2000-08-30
Last modified:2024-02-07
Method:X-RAY DIFFRACTION (2.3 Å)
Cite:Crystal structure of the catalytic subunit of Cdc25B required for G2/M phase transition of the cell cycle.
J.Mol.Biol., 293, 1999
1D4S
DownloadVisualize
BU of 1d4s by Molmil
HIV-1 PROTEASE V82F/I84V DOUBLE MUTANT/TIPRANAVIR COMPLEX
Descriptor: N-(3-{(1R)-1-[(6R)-4-HYDROXY-2-OXO-6-PHENETHYL-6-PROPYL-5,6-DIHYDRO-2H-PYRAN-3-YL]PROPYL}PHENYL)-5-(TRIFLUOROMETHYL)-2-PYRIDINESULFONAMIDE, PROTEIN (HIV-1 PROTEASE)
Authors:Watenpaugh, K.D, Janakiraman, M.N.
Deposit date:1999-10-05
Release date:1999-10-12
Last modified:2024-02-07
Method:X-RAY DIFFRACTION (2.5 Å)
Cite:Structure-based design of HIV protease inhibitors: sulfonamide-containing 5,6-dihydro-4-hydroxy-2-pyrones as non-peptidic inhibitors.
J.Med.Chem., 39, 1996
1D4Y
DownloadVisualize
BU of 1d4y by Molmil
HIV-1 PROTEASE TRIPLE MUTANT/TIPRANAVIR COMPLEX
Descriptor: N-(3-{(1R)-1-[(6R)-4-HYDROXY-2-OXO-6-PHENETHYL-6-PROPYL-5,6-DIHYDRO-2H-PYRAN-3-YL]PROPYL}PHENYL)-5-(TRIFLUOROMETHYL)-2-PYRIDINESULFONAMIDE, PROTEIN (HIV-1 PROTEASE)
Authors:Watenpaugh, K.D, Janakiraman, M.N.
Deposit date:1999-10-06
Release date:1999-10-13
Last modified:2024-02-07
Method:X-RAY DIFFRACTION (1.97 Å)
Cite:Structure-based design of HIV protease inhibitors: sulfonamide-containing 5,6-dihydro-4-hydroxy-2-pyrones as non-peptidic inhibitors.
J.Med.Chem., 39, 1996
5FX2
DownloadVisualize
BU of 5fx2 by Molmil
COMPARISON OF THE CRYSTAL STRUCTURES OF A FLAVODOXIN IN ITS THREE OXIDATION STATES AT CRYOGENIC TEMPERATURES
Descriptor: FLAVIN MONONUCLEOTIDE, FLAVODOXIN
Authors:Watt, W, Watenpaugh, K.D.
Deposit date:1991-10-17
Release date:1993-10-31
Last modified:2024-03-13
Method:X-RAY DIFFRACTION (1.9 Å)
Cite:Comparison of the crystal structures of a flavodoxin in its three oxidation states at cryogenic temperatures.
J.Mol.Biol., 218, 1991
4FX2
DownloadVisualize
BU of 4fx2 by Molmil
COMPARISON OF THE CRYSTAL STRUCTURES OF A FLAVODOXIN IN ITS THREE OXIDATION STATES AT CRYOGENIC TEMPERATURES
Descriptor: FLAVIN MONONUCLEOTIDE, FLAVODOXIN
Authors:Watt, W, Watenpaugh, K.D.
Deposit date:1991-10-17
Release date:1993-10-31
Last modified:2024-02-28
Method:X-RAY DIFFRACTION (1.9 Å)
Cite:Comparison of the crystal structures of a flavodoxin in its three oxidation states at cryogenic temperatures.
J.Mol.Biol., 218, 1991
3FX2
DownloadVisualize
BU of 3fx2 by Molmil
COMPARISON OF THE CRYSTAL STRUCTURES OF A FLAVODOXIN IN ITS THREE OXIDATION STATES AT CRYOGENIC TEMPERATURES
Descriptor: FLAVIN MONONUCLEOTIDE, FLAVODOXIN
Authors:Watt, W, Watenpaugh, K.D.
Deposit date:1991-10-17
Release date:1993-10-31
Last modified:2024-02-21
Method:X-RAY DIFFRACTION (1.9 Å)
Cite:Comparison of the crystal structures of a flavodoxin in its three oxidation states at cryogenic temperatures.
J.Mol.Biol., 218, 1991
2FX2
DownloadVisualize
BU of 2fx2 by Molmil
COMPARISON OF THE CRYSTAL STRUCTURES OF A FLAVODOXIN IN ITS THREE OXIDATION STATES AT CRYOGENIC TEMPERATURES
Descriptor: FLAVIN MONONUCLEOTIDE, FLAVODOXIN
Authors:Watt, W, Watenpaugh, K.D.
Deposit date:1991-10-17
Release date:1993-10-31
Last modified:2024-02-14
Method:X-RAY DIFFRACTION (1.9 Å)
Cite:Comparison of the crystal structures of a flavodoxin in its three oxidation states at cryogenic temperatures.
J.Mol.Biol., 218, 1991
1I1B
DownloadVisualize
BU of 1i1b by Molmil
CRYSTAL STRUCTURE OF RECOMBINANT HUMAN INTERLEUKIN-1BETA AT 2.0 ANGSTROMS RESOLUTION
Descriptor: INTERLEUKIN-1 BETA
Authors:Finzel, B.C, Watenpaugh, K.D, Einspahr, H.M.
Deposit date:1989-12-05
Release date:1990-01-15
Last modified:2024-02-07
Method:X-RAY DIFFRACTION (2 Å)
Cite:Crystal structure of recombinant human interleukin-1 beta at 2.0 A resolution.
J.Mol.Biol., 209, 1989
2HPE
DownloadVisualize
BU of 2hpe by Molmil
COMPARISON OF THE STRUCTURES OF HIV-2 PROTEASE COMPLEXES IN THREE CRYSTAL SPACE GROUPS WITH AN HIV-1 PROTEASE COMPLEX STRUCTURE
Descriptor: HIV-2 PROTEASE, UNIDENTIFIED PEPTIDE FRAGMENT
Authors:Mulichak, A.M, Watenpaugh, K.D.
Deposit date:1994-09-21
Release date:1994-10-15
Last modified:2024-02-14
Method:X-RAY DIFFRACTION (2 Å)
Cite:Comparison of the Structures of HIV-2 Protease Complexes in Three Crystal Space Groups with an HIV-1 Protease Complex Structure
To be Published
2HPF
DownloadVisualize
BU of 2hpf by Molmil
COMPARISON OF THE STRUCTURES OF HIV-2 PROTEASE COMPLEXES IN THREE CRYSTAL SPACE GROUPS WITH AN HIV-1 PROTEASE COMPLEX STRUCTURE
Descriptor: HIV-2 PROTEASE, UNIDENTIFIED PEPTIDE FRAGMENT
Authors:Mulichak, A.M, Watenpaugh, K.D.
Deposit date:1994-09-21
Release date:1994-10-15
Last modified:2024-02-14
Method:X-RAY DIFFRACTION (3 Å)
Cite:Comparison of the Structures of HIV-2 Protease Complexes in Three Crystal Space Groups with an HIV-1 Protease Complex Structure
To be Published

 

12>

229183

PDB entries from 2024-12-18

PDB statisticsPDBj update infoContact PDBjnumon